rxstatShortages › Clodronate Disodium

Clodronate Disodium shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Clodronate Disodium products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 of 2
Reports on file
2

Reports by product

Discontinued
BONEFOS
60MG · SOLUTION · BAYER INC
DIN 01984837
Discontinued
BONEFOS
400MG · CAPSULE · BAYER INC
DIN 01984845

What's happening

One or more Clodronate Disodium products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Clodronate Disodium is classified under “DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION” (ATC M05BA02).

Recent changes

Common questions

When will Clodronate Disodium be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Clodronate Disodium in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs affecting bone structure and mineralization)

All drugs affecting bone structure and mineralization shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.